Results

Total Results: 407 records

Showing results for "company".

281. pneumonia-antibiotic-treatment-protocol-130718 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
     July 19, 2013 - pneumonia-antibiotic-treatment-protocol-130718 Source: www.effectivehealthcare.ahrq.gov Published online: July 19, 2013 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Nosocomial Pneumonia I…

282. Making Healthcare Safer IV Rapid Review: Supply Chain Disruption Monitoring Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
     April 01, 2025 - Making Healthcare Safer IV Rapid Review: Supply Chain Disruption Monitoring Programs Making Healthcare Safer IV Supply Chain Disruption Monitoring Programs Rapid Review Structured Abstract Objectives. To summarize recent relevant literature on supply chain disruption monitoring programs in healthcare se…

283. Disposition of Comments_Comparative Effectiveness Review No. 256: Effectiveness of Telehealth for Women's Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
     June 16, 2022 - Disposition of Comments_Comparative Effectiveness Review No. 256: Effectiveness of Telehealth for Women's Preventive Services Comparative Effectiveness Review Disposition of Comments Report Title: Effectiveness of Telehealth for Women’s Preventive Services Draft report available for public comment…

284. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
     January 01, 2016 - 9 32 NA 7 34 NA McCall, 2008 3 SGA Intubating laryngeal mask airway (ILMA), Laryngeal Mask Airway Company … 42 10 NA 26 20 NA McCall, 2008 3 SGA Intubating laryngeal mask airway (ILMA), Laryngeal Mask Airway Company … html], pharyngeal-cuff-type esophageal obstructive airway [New EOA; Sumiway WB®, Sumitomo Bakelite Company

285. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Pulmonary Arterial Hypertension: Screening, Management, and Treatment Draft review available for public commen…

286. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-future_research.pdf
     February 01, 2013 - Template for Draft Reports Future Research Needs Paper Number 37 Physical Therapy for Knee Pain Secondary to Osteoarthritis: Future Research Needs Future Research Needs Paper Number 37 Physical Therapy for Knee Pain Secondary to Osteoarthritis: Future Research Needs Identification of Future Research …

287. Colorectal-Cancer-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
     February 01, 2012 - sites of genes are hypermethylated leading to suppression of gene transcription.7 Thus far a single company

288. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - the phase III BROADEN (Brodmann Area 25 Deep Brain Neurostimulation). 20 According to a July 2011 company

289. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
     January 01, 2012 - Popchilla is a small, emotionally expressive interactive robot developed by Interbots, a spin-off company

290. Research White Paper: A Framework To Facilitate the Use of Systematic Reviews and Meta-analyses in the Design of Primary Research Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/primary-research-design_research.pdf
     January 01, 2012 - New York: WH Freeman and Company; 1986. 17. Knipschild P. Systematic reviews: some examples.

291. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - For instance, a company that offers a well-used test that produces dichotomous, qualitative results —

292. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Covidien, plc (Dublin, Ireland), 510(k) clearance for the Cytosponge in November 2014 before the company

293. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - For instance, a company that offers a well-used test that produces dichotomous, qualitative results —

294. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Administration FDA Status UA/NSTEMI-Related FDA Indications Angiomax® Bivalirudin The Medicines Company

295. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - Saunders Company; 1999:543-99. 7. Lloyd-Jones D, Adams RJ, Brown TM, et al.

296. Alcohol-Misuse Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
     April 28, 2010 - Source: www.effectivehealthcare.ahrq.gov Published Online: July 21, 2011 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse Amendment Date(s) if applicable: Not applicable (Amendments Detail…

297. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv…

298. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: The Effectiveness of Disease-modifying Anti-rheumatic drugs (DMARDs) in Children with Juvenile Idio…

299. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
     February 25, 2014 - Disposition of Comments Report for Comparative Effectiveness Review No. 131 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Pharmacologic Therapies for the Management of Crohn’s Disease: Comparative Effectiveness Draft review available for public commen…

300. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - Introduction -KQ 1 In the Executive Summary on page ES-6 and on page 6, Amgen requests that the company … Only a single company, Merck, is singled out by name as a potential source of bias.